These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12470803)
1. Testing times for the "amyloid cascade hypothesis". Hardy J Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803 [No Abstract] [Full Text] [Related]
2. Bioflocculant hypothesis: a partial endorsement. Terry R Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804 [No Abstract] [Full Text] [Related]
3. Amyloid-beta: a (life) preserver for the brain. Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809 [No Abstract] [Full Text] [Related]
4. Evolution and the scientific method. Tucker HM; Estus S Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808 [No Abstract] [Full Text] [Related]
5. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Savory J; Ghribi O; Herman MM Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807 [No Abstract] [Full Text] [Related]
6. Abeta conformational change is central to Alzheimer's disease. Holtzman DM Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806 [No Abstract] [Full Text] [Related]
7. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Robinson SR; Bishop GM Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802 [TBL] [Abstract][Full Text] [Related]
8. The amyloid hypothesis: let sleeping dogmas lie? Bishop GM; Robinson SR Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810 [TBL] [Abstract][Full Text] [Related]
14. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Huichalaf CH; Al-Ramahi I; Park KW; Grunke SD; Lu N; de Haro M; El-Zein K; Gallego-Flores T; Perez AM; Jung SY; Botas J; Zoghbi HY; Jankowsky JL Hum Mol Genet; 2019 Jun; 28(12):2014-2029. PubMed ID: 30753434 [TBL] [Abstract][Full Text] [Related]
15. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276 [TBL] [Abstract][Full Text] [Related]
16. Persistence of Aβ seeds in APP null mouse brain. Ye L; Fritschi SK; Schelle J; Obermüller U; Degenhardt K; Kaeser SA; Eisele YS; Walker LC; Baumann F; Staufenbiel M; Jucker M Nat Neurosci; 2015 Nov; 18(11):1559-61. PubMed ID: 26352792 [TBL] [Abstract][Full Text] [Related]
17. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]
18. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice. Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600 [TBL] [Abstract][Full Text] [Related]
19. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377 [TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]